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Postsynaptic density-95 is a multidomain scaffolding protein
that recruits glutamate receptors to postsynaptic sites and facil-
itates signal processing and connection to the cytoskeleton. It is
the leading member of the membrane-associated guanylate
kinase family of proteins, which are defined by the PSD-95/
Discs large/ZO-1 (PDZ)-Src homology 3 (SH3)-guanylate
kinase domain sequence.We usedNMR to show that phosphor-
ylation of conserved tyrosine 397, which occurs in vivo and is
located in an atypical helical extension (3), initiates a rapid
equilibrium of docked and undocked conformations. Undock-
ing reduced ligand binding affinity allosterically and weakened
the interaction of PDZ3 with SH3 even though these domains
are separated by a 25-residue linker. Additional phosphoryla-
tion at two linker sites further disrupted the interaction, impli-
cating3 and the linker in tuning interdomain communication.
These experiments revealed a novel mode of regulation by a
detachable PDZ element and offer a first glimpse at the dynamic
interaction of PDZ and SH3-guanylate kinase domains inmem-
brane-associated guanylate kinases.
Phosphorylation is one of the most common modifications
made to proteins. Depending on the protein substrate, it can
regulate the gain or loss of activity through a variety of mecha-
nisms. Most mechanisms studied to date appear to work via a
change in steric geometry at the active site or a global confor-
mational change in the protein (1–3), although a few recent
examples indicate modulation of protein dynamics that can
yield a graded response (4, 5). In some cases, phosphorylation
simply provides a protein-protein recognition site (6). Overall,
the extent of structural characterization of phosphorylation
mechanisms is limited given the ubiquity of this post-transla-
tional signaling mechanism and the large diversity of effects
observed upon phosphorylation. A greater understanding of
how phosphorylation(s) modulates protein activity is essential
for a mechanistic understanding of signal transduction.
Many phosphorylated proteins are multidomain, modular
proteins (2–4). One class of such proteins that shape signal
transduction is the scaffolding proteins, which are frequently
phosphorylated (7). Membrane-associated guanylate kinase
(MAGUK)2 family proteins are multidomain scaffolding pro-
teins that play roles in ion channel clustering, intracellular traf-
ficking, signal transduction, and cell-cell adhesion (8–10).Mal-
function ofMAGUKs is associated with central nervous system
disorders (11). The defining MAGUK signature is the PDZ-
SH3-guanylate kinase “supradomain” architecture. The best
known MAGUK protein is postsynaptic density-95 (PSD-95),
which is found on the cytoplasmic side of postsynaptic termi-
nals. PSD-95 is a non-catalytic scaffolding protein that clusters
glutamate receptors and assemblesmacromolecular complexes
for signal integration in the postsynapse at excitatory neurons
(8, 12). It consists of three PDZ domains, an SH3 domain, and a
non-catalytic guanylate kinase (GK) domain (see Fig. 1A). PDZ
domains are 90-residue, globular, protein interaction
domains that have a conserved fold comprised of two -helices
and six -strands. The function of PDZs is typically to bind the
C-terminal 4–5 residues of target proteins, which bind in a
groove between 2 and 2 of the PDZ. PDZ domains are often
found in tandem copies and are common to proteins that func-
tion as scaffolds for assembling signaling complexes or traffick-
ing components at cell-cell junctions. In PSD-95, the three PDZ
domains bind many proteins ranging from NMDA and adre-
nergic receptors to neuronal nitric-oxide synthase, Pyk2, syn-
aptic Ras GTPase activating protein, and microtubule assem-
blies (13). Structural work has been carried out on individual
PDZs of PSD-95 (14, 15) as well as the SH3-GKmodule (16, 17).
However, little is known about how MAGUK PDZ domains
associate/function with the SH3-GK module. A role for PDZs
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emerged from examples in which intermolecular (or interdo-
main) contacts occur on novel PDZ interfaces (18, 19) or bind-
ing is regulated allosterically (18, 20–23).
Previous work suggests that the third PDZdomain (PDZ3) in
PSD-95 family proteins regulates activity at SH3-GK, indicating
that this PDZ domain may have an additional regulatory func-
tion on top of its C-terminal binding function. MAP1a binds to
the GK domain of PSD-95; however, this interaction is weak-
ened by the presence of PDZ3 (and abolished by the presence of
all three PDZ domains) and restored by PDZ-binding peptides
such as adenomatous polyposis coli, NR2B, and cysteine-rich
PDZ-binding protein (24). Interdomain interactions were also
characterized in the Drosophila homologue of PSD-95, Dlg-1,
in which the domain interaction between PDZ3 and SH3 was
regulated by PDZ3-binding peptides (25). The region linking
PDZ3 and SH3 is vital to the interdomain communication
between these two domains: replacement of the conserved
linker region with flexible Gly-Ser repeats disrupts the influ-
ence that PDZ3 has on the binding of SH3 to its interaction
partner, GukHolder (25). Thus, a major question regarding
MAGUKs is what is the role of the PDZ domain preceding
SH3-GK and how might it participate in intramolecular, inter-
domain interactions?
Interestingly, PSD-95 is known to be phosphorylated at up to
12 siteswith several of these sites occurring at linker positions
in between structured domains as well as one in a C-terminal
helical extension to PDZ3 (see Fig. 1A). To date, phosphoryla-
tion has received modest attention as a means of regulating
PDZ domain function in general. One exception is the PDZ
protein NHERF1 for which phosphorylation has been shown to
regulate PDZ-mediated autoinhibition (26). Recently, we
showed that folding of a C-terminal extension to PDZ3 into an
-helix (third -helix (3)) increases binding affinity to PDZ3
ligand via an allosteric mechanism rooted in changes in pico-
second-nanosecond side-chain dynamics (21). The 3 helix is
not part of the conserved PDZ fold and hence appeared as an
unusual auxiliary element whose function had been unclear.
Within the 3 helix, Tyr-397 has been shown to be phosphor-
ylated (27), which in principle could either increase or decrease
3 interactions with the PDZ core. In addition to Tyr-397, the
nearby residues Ser-415 and Ser-418 can also be phosphory-
lated (28, 29). This dense collection of phosphorylation sites
suggests that this region (C-terminal extension of PDZ3 and the
PDZ3-SH3 linker) is a hot spot for MAGUK regulation. Inter-
estingly, structured “extensions” to PDZ domains are now
being discovered in more PDZ domains (30).
To probe the role of PDZ3 in the PSD-95 MAGUK and its
transition into the linker and SH3 domain, we chose to study by
NMR the effect of phosphorylation at three sites in the C-ter-
minal region of PDZ3 and how such phosphorylations modu-
late PDZ3 structure, function, and its interactionwith SH3-GK.
AconstructofPDZ3spanningresidues304–402wasphosphor-
ylated at Tyr-397 (p397-PDZ3) and characterized for structural
effects. A combination of chemical shift analysis, hydrogen
exchange, 15N relaxation, and isothermal titration calorimetry
showed that phosphorylation induces a fast equilibrium
between a docked conformation in which 3 is packed against
the PDZ core and a conformational state in which 3 is
undocked that has reduced affinity for PDZ3 ligands. The latter
state was previously identified via truncation of 3 and shown
to alter PDZ3 ligand binding affinity through a novel allosteric
mechanism driven by side-chain dynamics (21). The findings
here support this mechanism by showing that the dynamic
allostery can be triggered by a biologically relevantmodification
and is likely to be utilized in a cellular context. In a second
constructofPSD-95 that includesPDZ3-linker-SH3,phosphor-
ylation at all three sites (397, 415, and 418) was shown to
increase the mobility of PDZ3 relative to SH3. These studies
provide insight into how phosphorylation affects structure and
dynamics of an intrinsically flexible, multidomain system. They
also show for the first time that the association of PDZ3with the
SH3 domain in PSD-95 is weakened by multiple
phosphorylations.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification—PDZ3 (residues 304–
402), Y397E-PDZ3, andPDZ3-SH3 tandem (residues 304–532)
from rat PSD-95 were subcloned into the pET21a vector with a
tobacco etch virus-cleavable N-terminal histidine tag. The
PDZ3-SH3 tandem was stabilized by adding the sequence
SGSGSGPYIWVPAREERL to its C terminus (16) where bold
residues are from residues 713 to 724, which form the F-strand
of the SH3 domain. Y397E-PDZ3, PDZ3-SH3 single mutant
(Y937E-PDZ3-SH3), and triple mutant (Y397E/S415E/S418E)
were made by multiple site mutagenesis PCR (31). Trans-
formed Escherichia coli BL21(DE3) cells were grown at 37 °C in
LB medium or minimal medium containing appropriate iso-
topes. When cell density reached an A600 of 0.6, isopropyl
1-thio--D-galactopyranoside was added to a final concentra-
tion of 1mM, and the cells were grown for another 16 h at 22 °C.
The cells were harvested by centrifugation and stored at80 °C
until use.
To purify all proteins in this study, the cell pellets were resus-
pended in 50 mM Tris-HCl, pH 8.0, 200 mM NaCl, 0.1% Triton
X-100, 25mM imidazole, and 1mM lysozyme. The resuspended
cells were frozen and thawed for three cycles, and sonication
was applied. The centrifuged cell lysate was loaded to a nickel
affinity column and eluted with 500 mM imidazole. The frac-
tions containing target proteins were pooled and subjected to
overnight tobacco etch virus cleavage at 4 °C. A 100% cleavage
was achieved as suggested by SDS-PAGE. Cleaved samples
were further purified by Source Q ion exchange chromatogra-
phy followed by a G50 size exclusion column equilibrated in a
buffer containing 22 mM NaPO4, pH 6.8, 55 mM NaCl, and 1.1
mM EDTA. p397-PDZ3 was separated from PDZ3 using Source
Q resin with a 260-ml linear gradient from 0 to 500mMNaCl in
20mMTris-HCl, pH 7.0 (Fig. 2A). The identity and purity of the
protein were verified by mass spectrometry and SDS-PAGE.
Protein concentrations were determined by UV absorbance
with extinction coefficients calculated by the ProtParam tool.
Phosphorylation changes theUV absorbance profile of tyrosine
with an extinction coefficient of 593 M1 cm1 at 268 nm (32).
Taking the other unphosphorylated tyrosine (Tyr-392; 268 
1114 M1 cm1) into account, the concentration of p397-PDZ3
was determined using an extinction coefficient of 1707 M1
cm1 at 268 nm.
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PDZ3-SH3 single and triple mutants were purified using the
aforementioned protocol with modification at the size exclu-
sion chromatography step where elution buffer contained 50
mM Tris-HCl, pH 7.5, 200 mM NaCl, and 1 mM DTT. The plas-
mid encoding c-Src kinase was a gift from John Kuriyan (Uni-
versity of California, Berkeley) and Sharon Campbell (Univer-
sity of North Carolina at Chapel Hill). The c-Src kinase domain
was purified as described (33).
Peptide Synthesis—A7-mer CRIPT peptide (Ac-NYKQTSV-
COOH) was synthesized and purified as reported (21). The
identity and purity of the peptide were verified by mass spec-
trometry. The peptide concentrationwas determined usingUV
absorbance with an extinction coefficient of 1490 M1 cm1.
Isothermal Titration Calorimetry Experiments—ITC experi-
ments were carried out on a MicroCal VP-ITC microcalorim-
eter and repeated twice to estimate error. ITCmeasurements of
PDZ3, p397-PDZ3, and Y397E-PDZ3 were performed by titrat-
ing 1mMCRIPT peptide into 0.1 mM protein. In total, 280 l of
CRIPT peptide was titrated into 1.4ml of protein solution by 40
steps with a 3-min interval between injections. The dilution
effect was estimated by performing the same titration proce-
dure without protein. Both the peptide and proteins were dis-
solved in the same buffer containing 20 mM NaPO4, pH 6.8, 50
mMNaCl, and 1 mM EDTA. Data were integrated and analyzed
using Origin version 5.0 (MicroCal). Kd, H, S, and N were
fitted with a single binding site model. For PDZ3, p397-PDZ3,
and Y397E-PDZ3 titrations, c values were 27.8, 7.2, and 12.6,
respectively.
NMR Assignments and Relaxation Experiments—PDZ3,
p397-PDZ3, and Y397E-PDZ3 NMR samples were dissolved in
20mMNaPO4, pH 6.8, 50mMNaCl, 1mM EDTA, and 10%D2O
at a protein concentration of 1mM. NMR assignment data were
acquired on a Varian Inova 500-MHz magnet equipped with a
room temperature 1H/15N/13C probe and z axis pulsed field
gradients. Backbone resonance assignments for p397-PDZ3 and
Y397E-PDZ3 were obtained using three-dimensional
HNCACB and CBCA(CO)NH experiments (34).
For characterization of backbone dynamics of p397-PDZ3,
15NT1,T2, and {1H}-15NNOE data (supplemental Fig. S1) were
collected at 500 MHz at a protein concentration of 1 mM. Data
were acquired and analyzed as reported elsewhere (21, 35)
using in-house programs. Briefly, T1, T2, and {1H}-15N NOE
data from “rigid” residues were initially fit to obtain the overall
correlation time of the protein, which was determined to be 6.8
ns. As with unphosphorylated PDZ3, anisotropic models of
tumbling were not required (21).Models were then selected for
individual residues (supplemental Table S1) to fit the Lipari-
Szabo dynamics parameters (S2, e, etc.).
15N T2 relaxation data for wild-type PDZ3-SH3 and Y397E-
PDZ3-SH3 and Y397E/S415E/S418E-PDZ3-SH3mutants were
acquired at a protein concentration of 0.5 mM. Data were col-
lected as described (21) on a Varian Inova 500-MHz system
equipped with a 1H/15N/13C cryogenically cooled probe with z
axis pulsed field gradients. Wild-type and mutant PDZ3-SH3
constructs were dissolved in a buffer containing 50 mM Tris-
HCl, pH 7.5, 200mMNaCl, 10%D2O, and 1mMDTT. All NMR
spectra were processed by NMRPipe and analyzed by
NMRViewJ.
Solvent-exposed Amide (SEA)-HSQC Experiments—Solvent-
exposed amide HSQC spectra were collected at 500MHz using
a 1H/15N/13C probe and z axis pulsed field gradients at 298 K.
The original SEA-HSQC pulse sequence was developed by Lin
et al. (36) using a clean chemical exchange-phase modulat-
ed-PM mixing scheme. In this study, a Biopack version of the
SEA-HSQC pulse sequence was used. The intertransient delay
was set to 1.5 s, and the mixing time was 0.1 s. The spectra of
PDZ3 and p397-PDZ3were collected at a protein concentration
of 1 mM with 16 transients. NMR intensity is a function of sev-
eral factors such as protein concentration, nuclear relaxation
time, solution conductivity, and protein tumbling time. Of
these factors, protein tumbling time is significantly influenced
by phosphorylation (see “Results”). This necessitates a method
to scale the SEA-HSQC intensities of PDZ3 and p397-PDZ3 to
allowdirect comparison.The scalingprocedureused the residues
that are not affected by phosphorylation, i.e. those residues that
experience slight or nearly no chemical shift perturbation as
shown in Fig. 2A. The SEA-HSQC peak intensities of p397-PDZ3
for these residues were scaled tomatch those of PDZ3.
RESULTS
Phosphorylation of Tyr-397 and Purification of Phosphory-
lated PDZ3—From the crystal structure of PDZ3 (14), the side
chain of Tyr-397 is partially buried between 3 and the core
domain of PDZ3 (Fig. 1B). This tyrosine residue is phosphory-
lated in mouse brain (27), although it is unknown which kinase
in vivo is responsible for its phosphorylation. Tyr-397, located
at the linker between PDZ3 and SH3, is highly conserved
throughout MAGUK proteins of various organisms (Fig. 1A).
Using the ExPASy Proteomics Server, we analyzed the first 100
homologue sequences of PSD-95, which belong to different
organisms, different subfamilies, and different splicing forms.
Only one conservedmutation (Tyr to Phe) was found. The high
conservation of Tyr-397 implies its significance within the
MAGUK family.Members of the Src family are known to inter-
act with PSD-95 (37). Using the Group-based Prediction Sys-
tem (38), Src kinase was predicted to be capable of phosphory-
lating Tyr-397. Treatment of 15N-labeled PDZ3 with c-Src
resulted in a new set of resonances in the HSQC spectrum of
PDZ3. The relative peak intensities suggested that only 10% of
PDZ3 was phosphorylated. The reaction went further to com-
pletion after removing ADP by dialysis and adding fresh ATP,
which was repeated four times. This yielded 40% putative
p397-PDZ3.
Ion exchange chromatography was used to purify p397-PDZ3
based on the additional negative charge introduced by phos-
phorylation. The elution profile displayed five discrete species,
three of which tested positive for protein (Fig. 2A). The first
peakwas confirmed to be PDZ3 fromHSQC, and the third peak
was confirmed to be pure phospho-PDZ3. An overlay of HSQC
spectra of PDZ3 and putative p397-PDZ3 shows peaks shifting
in regions of PDZ3 consistent with modification at Tyr-397
(Fig. 2B). The identity of the third peak was also analyzed by
mass spectrometry (supplemental Fig. S2). Although the elec-
trospray ionization ion trap mass spectrum indicated the cor-
rect mass for a singly phosphorylated species (supplemental
Fig. S2A), MS-MS MALDI-TOF results suggested that the
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dominant species of the third peak was p397-PDZ3, although
small amounts of p392-PDZ3 (10%) could not be not ruled out
(supplemental Fig. S2B). A species other than p397-PDZ3 was
not found in 1H-15N HSQC, HNCO, HNCACB, or CBCA-
(CO)NH spectra. Based on this, the following NMR-based
observations were interpreted to arise solely from p397-PDZ3.
The above procedurewas used to obtainmilligramquantities of
p397-PDZ3 for further biophysical characterization.
Phosphorylation-inducedUndocking of 3 Lowers Affinity for
CRIPT Ligand—To determine the effect of phosphorylation at
Tyr-397 on PDZ3 structure, the backbone chemical shifts of
p397-PDZ3 were assigned and compared with unphosphory-
lated PDZ3 (Fig. 3A). These chemical shift perturbations
(CSPs) were thenmapped onto the structure of PDZ3 (Fig. 3B).
Phosphorylation resulted in CSPs radiating out from Tyr-397
to include all of 3 and its surrounding regions. Although the
perturbation pattern is consistent with the general site of phos-
phorylation, the extent and specific nature of any structural
change accompanying phosphorylation is more difficult to
assess strictly from CSPs.
In unphosphorylated PDZ3, the side chain of Tyr-397 packs
into side chains of the 2 strand, the 3 strand, and the 1-4
loop of the PDZ core. These hydrophobic interactions help to
define how 3 packs against the PDZ core (Fig. 3B). One pos-
sible consequence of phosphorylation is therefore destabiliza-
tion/unfolding of 3 because the phosphate group might
occlude proper packing of 3. In this sense, phosphorylation of
Tyr-397 would effectively convert PDZ3 into a C-terminally
truncated form, much like PDZ(303–395) characterized previ-
ously and referred to as 7ct (21). To test this idea, we com-
pared [1H, 15N] amide chemical shifts of PDZ3, p397-PDZ3, and
7ct by superimposing HSQCs of the three proteins. Nearly all
residues experiencing significant CSPs in p397-PDZ3 (Fig. 3)
display a linear trend of HSQC peaks in the order PDZ3, p397-
PDZ3, and 7ct (Fig. 4A). To quantitatively demonstrate line-
arity of these three sets of resonances, correlation values
FIGURE 1. Domain architecture of PSD-95 and crystal structure of PDZ3. A, the five domains of PSD-95 are shown, and the sequences of the 3 region and
PDZ3-SH3 linker in MAGUK family from different organisms are aligned. The conserved tyrosine (Tyr-397) and two serine phosphorylation sites (Ser-415 and
Ser-418) are denoted by “*.” The alignment was done using ClustalX 2.0.12. RAT, Rattus norvegicus; MOUSE, Mus musculus; XENTR, Xenopus (Silurana) tropicalis;
TETNG, Tetraodon nigroviridis; DANRE, Danio rerio; AILME, Ailuropoda melanoleuca; APLCA, Aplysia californica; BRAFL, Branchiostoma floridae (Florida lancelet)
(amphioxus); SACKO, Saccoglossus kowalevskii (acorn worm); DROME, Drosophila melanogaster; BRUMA, Brugia malayi (filarial nematode worm). B, the crystal
structure of PDZ3 (Protein Data Bank code 1BFE) is shown in the schematic. Tyr-397 is shown in sticks. The 3 is shown in red..
FIGURE 2. Purification of p397-PDZ3. A, ion exchange chromatography elution profile of p397-PDZ3 purification monitored by UV absorbance at 280 nm. The
NaCl elution gradient is shown as straight lines. B, 15N HSQC of p397-PDZ3 (red) and PDZ3(304 – 402) (black). The resonances of residues at 3 are indicated.
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(adjusted R values) of linear fitting were calculated and plotted
(Fig. 4B). Most R values are around 1, indicating high linearity
formany residues. Because chemical shifts are highly nonlinear
with respect to positioning of structural elements, such exten-
sive linearity cannot be reasonably explained as accidental.
Rather, the simplest explanation is that the peak positions of
p397-PDZ3 are averaged due to fast exchange between two con-
formations: one in which 3 is packed as in native PDZ3 and
one in which 3 is undocked and makes no contributions to
chemical shifts in PDZ core residues. Thus, p397-PDZ3 exists as
an equilibrium of two dynamically exchanging states repre-
sented by PDZ3 and 7ct, respectively. Preliminary 15N Carr-
Purcell-Meiboom-Gill relaxation dispersion experiments (39)
on p397-PDZ3 did not detect this exchange; and thus, we con-
clude that exchange takes place on themicrosecond or possibly
even nanosecond timescale. Because p397-PDZ3 peaks
occurred on average approximately half-way between unphos-
phorylated PDZ3 and 7ct peaks, the fraction of undocked 3
was estimated to be 50%.
It was shown previously that truncation of 3 decreases
binding affinity of PDZ3 with CRIPT peptide by 21-fold (21). If
p397-PDZ3 is indeed a mixture of PDZ3- and 7ct-like states,
an intermediate binding affinity to CRIPT peptide should be
observed. To test this, we performed ITC experiments tomeas-
ure the binding affinity of p397-PDZ3 toCRIPTC-terminal pep-
tide. The binding affinity of p397-PDZ3 was found to be 4
times weaker than PDZ3, falling in between PDZ3 and 7ct
(Table 1). Importantly, this change in Kd due to phosphoryla-
tion ismainly attributed to entropy, which is the same signature
observed for 7ct (21).
Phosphorylation of Tyr-397 Increases Disorder in 3—Phos-
phorylation of Tyr-397 disrupts the packing of 3 with the core
domain of PDZ3 as described above. However, it is unknown
how phosphorylation affects the local structure of 3. Does 3
stillmaintain its secondary structurewhen3 is undocked from
PDZ3? To answer this question, we analyzed 13C chemical
shifts, amide exchange rates, and 15N backbone relaxation in
phosphorylated and unphosphorylated PDZ3.
The 13C chemical shift relative to random coil values is a
sensitive indicator of secondary structure (40). These relative
chemical shift values for unphosphorylated PDZ3 and p397-
PDZ3 are shown for the C-terminal residues that include
5385–392 and 3394–398 (Fig. 5). Phosphorylation clearly
FIGURE 3. CSP of Tyr-397 phosphorylation. The 15N HSQCs of PDZ3 and p397-PDZ3 were compared, and vector chemical shift changes of 1H and 15N are
plotted versus residue number (A) and onto the crystal structure of PDZ3 (B) using a color scale. The vector chemical shift perturbations were calculated as
1H  0.1  15N. Tyr-397 is rendered in sticks, residues 329 –336 (includes the 2-3 loop) are rendered in spheres, and residues without CSP data are
colored green. The graphic was prepared based on the structure of unliganded PDZ3 (Protein Data Bank code 1BFE).
FIGURE 4. Linear chemical shift pattern of PDZ3, p397-PDZ3, and 7ct 15N
HSQC peaks. A, four representative residues were selected to show the HSQC
resonance pattern of PDZ3, p397-PDZ3, and 7ct. HSQC peaks of p397-PDZ3
(green) fall onto the line defined by PDZ3 (blue) and 7ct (red) resonances. The
adjusted correlation value (R value) for each example residue is given in each
panel. B, adjusted correlation values (R values) of the resonances with signif-
icant chemical shift changes upon phosphorylation. Only the residues with
CSP 0.05 ppm were analyzed.
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diminished helicity in3 as determined from the 13C chemical
shift, whereas it had no effect on 5 structure.
Amide proton exchange reports on solvent accessibility and
the stability of secondary structure. We measured these
exchange rates using the SEA-HSQC experiment. This
approach was used because the amides in the 3 region
exchange rapidly (data not shown). In a SEA-HSQC spectrum,
the intensity of an amide resonance is proportional to the
extent to which it is solvent-exposed (36). As shown in supple-
mental Fig. S3A, only surface-exposed residues of PDZ3 are
observed in the spectrum. The undocking of 3 is expected to
increase solvent exposure, which should be evident from SEA-
HSQC intensity changes. However, it is not appropriate to
directly compare SEA-HSQC intensities of PDZ3 and phos-
pho-PDZ3 samples as intensities are differentially affected by
protein concentration and tumbling times. Therefore, intensi-
ties were normalized (see “Experimental Procedures”) to facil-
itate direct comparison. SEA-HSQC peak intensities of PDZ3
and p397-PDZ3 are plotted against one another in supplemental
Fig. S3B.A good correlation of these peak intensities is obtained
as indicated by an R value of 0.98, and a slope of 0.74 (for p397-
PDZ3 relative to PDZ3) was observed. As expected, 3 and its
docking region displayed increased solvent exchange (supple-
mental Fig. S3, C and D), whereas other regions have few sig-
nificant changes in solvent accessibility.
To directly determine the degree of flexibility in p397-PDZ3,
we used 15N backbone relaxation coupled with model-free
analysis (41) to yield an order parameter, S2, for each residue.
Themost significant change in S2 upon phosphorylation was in
the 3 region, which showed decreases of 0.1–0.3 (Fig. 6). For
residues in 3 with significant helicity (394–400), the average
decrease in S2, however, is only 0.10. Given that the undocked
fractionwas50% and that the docked state showed average S2
values of 0.85, this suggests that the undocked fraction yields
on average S2 values of 0.65 for residues 394–400; this is
much higher than expected for a fully unfolded C-terminal tail.
Thus, it is more likely that upon undocking these “3” residues
redistribute some of their helical character into a mixture of
extended and random coil-like states with the latter contribut-
ing most significantly to a decrease in S2. This would allow for
relatively high S2 values and the observed 13C chemical shifts
because extended backbone conformations would help to
reduce the downfield shifts from random coil values (Fig. 5). In
addition to S2 effects at the C terminus, a slight overall decrease
in S2 was observed throughout the PDZ core that is suggestive
of an overall small increase in backbone dynamics in p397-
PDZ3. These results are similar to that found in 7ct, which
showed large increases in side-chain dynamics and subtle
increases in backbone dynamics (21). From the 15N relaxation
analysis, it is also noteworthy that protein tumbling was signif-
icantly retarded by the unfolding of 3 as indicated by the
increased global tumbling correlation time, m, which
increased from 5.9 to 6.8 ns upon phosphorylation at Tyr-397.
This tumbling time is also consistent with an increased volume
for the PDZ3 core (to be reported elsewhere).3
Phosphorylation Disrupts PDZ3-SH3 Association—In vivo,
phosphorylation does not occur in the specific PDZ construct
used here (residues 304–402), but rather, it occurs in the con-
text of full-length PSD-95 (Fig. 1A). Although it may not be
feasible to probe this 80-kDa protein for phosphorylation
effects by NMR, we hypothesized that some full-length behav-
iormight be captured in shortermultidomain constructs. Thus,
we set out to characterize the behavior of PDZ3 in a construct
that spans residues 304–532, which includes the SH3 domain
and the linker preceding it. In addition, the F-strand from the
GK domain (residue numbers 713–724) was added to the C
terminus to enhance stability (16). This PDZ3-SH3 construct
yielded reasonable quality HSQC spectra (supplemental Fig.
S4) from which the effects of phosphorylation could be
monitored.
In PDZ3 alone, phosphorylation at Tyr-397 initiated 3
undocking and a redistribution of its sampled conformations.
In the intact MAGUK, because 3 precedes a 25-residue
linker that connects to the SH3, phosphorylation may affect
putative domain packing between PDZ3 and SH3. To test this,
15N backbone transverse relaxation times (T2) were measured
in PDZ3-SH3. T2 times are highly sensitive to the rate of tum-
bling experienced by individual sites. An overall increase in T2
is expected for a reduced degree of domain-domain packing
because loss of packingwould lead tomore time spent tumbling
as an isolated domain. For these experiments, phosphorylation
at 397 in PDZ3-SH3 was mimicked by the Y397E mutation,
which yielded a 7-fold reduction in CRIPT binding affinity in
the context of the PDZ3 construct (supplemental Fig. S5). The
validity of the mimic was also confirmed by 13C chemical
shifts. These shifts indicate an almost identical loss of helicity
(relative to unphosphorylated PDZ3) in Y397E-PDZ3 com-
pared with p397-PDZ3 (Fig. 5).
T2 values for the mutant and wild-type constructs were
measured, and their differences are shown in Fig. 7A. In general,
Y397E-PDZ3-SH3 showed T2 values that are 3–25 ms longer
relative to wild type. The increase in T2 at virtually all residues
suggests that phosphorylation at Tyr-397 reduced the interac-
tion betweenPDZ3 and SH3,which appeared to be stabilized by
the presence of 3 helical secondary structure.
Two additional serine phosphorylation sites (Ser-415 and
Ser-418) within the PDZ3-SH3 linker region have been
reported (42). The fragment where Ser-415 and Ser-418 are
located corresponds to a fragment thatwas shown to contribute
to communication between PDZ3 and GK in the PSD-95
homologue Dlg-1 (25). Specifically, deletion or replacement of
this “2” fragment with random coil segments (from Gly-Ser
repeats) abolishes the PDZ3-depdendent interaction of the GK
domain with GukHolder. Because of the proximity of these res-
3 C. M. Petit, A. B. Law, P. J. Sapienza, J. Zhang, X. Zuo, and A. L. Lee, manuscript
in preparation.
TABLE 1
ITC binding parameters for PDZ3 and p397-PDZ3
CRIPT peptide (NYKQTSV) was titrated in, and each experiment was repeated
twice. The Kd between 7ct and CRIPT is 81 M.
Binding parameters PDZ3 p397-PDZ3
Stoichiometry 0.98 	 0.03 0.99 	 0.02
Kd (M) 3.60 	 0.28 14.00 	 0.47
H (kcal/mol) 8.57 	 0.31 8.80 	 0.29
TS (kcal/mol) 1.16 	 0.26 2.18 	 0.31
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idues to 3 and their conserved nature (Fig. 1B), we created a
triple phosphorylation mutant to test the effect of phosphoryl-
ation at these two additional sites. 15N T2 measurements were
made on a Y397E/S415E/S418E triple mutant of PDZ3-SH3.
Compared with the Y397E single mutant, the triple mutant
exhibited even higher T2 values (Fig. 7B), suggesting stronger
dissociation of PDZ3 and SH3 domains.
DISCUSSION
Regulation in PDZ Domains—When PDZ domains are
excised from their parent proteins, they typically behave as sim-
ple binders of C termini, which is documented by the many
determined structures of individual PDZs and their cognate
ligands (43). Current evidence indicates, however, that PDZ
function can be influenced by flanking sequences and/or
domains as well as intermolecular interactions (30). For exam-
ple, the PDZ domain of Par6 alters its binding affinity for ligand
upon binding of Cdc42 to the semi-Crib motif, which is imme-
diately N-terminal to the PDZ domain, and augments its
-sheet (18). In a reverse sense, “PDZ proteases” are regulated
by ligand-induced changes in PDZ structure (20). PDZ function
has also been shown to be regulated by redox events within the
PDZ domain (44), and this redox potential can be allosterically
regulated by binding to yet another PDZ domain (45). The idea
that PDZ domains are involved in higher order regulatory
events is consistent with their locations (often in tandem) in
proteins involved in organization of signaling complexes, sub-
cellular transport, and cell-cell adhesion (9, 43).
Here, we show how PDZ3 from PSD-95 is regulated by phos-
phorylation of Tyr-397, which lies outside the strict PDZ
boundary in a C-terminal extension that augments the PDZ
core structure (14, 21). Although phosphorylation was shown
to regulate function of the PDZ proteinNHERF1, the phospho-
rylation sites are far from the PDZ domains, and their precise
mechanism of release of autoinhibition remains to be eluci-
dated (26). In contrast to phosphorylation of PDZ domains
themselves, there are numerous examples of phosphorylation
of PDZ substrates (46–54). Phosphorylation typically occurs at
positions 2 to 4, and although this usually results in weak-
ening of the PDZ-ligand interaction, there are examples of
phosphorylation strengthening the interaction (49, 53, 54).
Thus, phosphorylation appears to be a recurring regulatory
mechanism in PDZ-mediated interactions. Although there is
currently little direct characterization of how phosphorylation
influences PDZ domains, proteomics work suggests that phos-
FIGURE 5. C chemical shift differences of PDZ3, p397-PDZ3, and Y397E-PDZ3 relative to random coil values. The C chemical shift differences were
calculated by subtraction of random coil C chemical shifts from those of PDZ3, p397-PDZ3, or Y397E-PDZ3. Only 5 and 3 are shown for clarity. The random
coil chemical shifts were used as reported by Wishart and Sykes (40).
FIGURE 6. Backbone amide order parameters (S2). The S2 was calculated
by subtraction of unphosphorylated PDZ3 S2 from p397-PDZ3 S2 values. The
residues with significant order parameter changes (S2  2) are shown as
filled bars. Data were acquired at 500 MHz. Error bar, S.D.
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phorylation in PDZ core or flanking sequences is relatively
common. As collected in the UniProt database, numerous
phosphorylation sites have been experimentally confirmed
(mostly inmurine proteins) for the PDZ proteins ZO-1, GRIP1,
MAGI2, MAGI3, and Par3, for example. Many of these phos-
phorylation sites exist in short linkers between domains as
observed here in PSD-95 but also within the PDZ domains.
Phosphorylation at Tyr-397 Allosterically Regulates Binding
of C Terminus—We successfully phosphorylated (at Tyr-397) a
construct of PDZ3 that includes an -helical C-terminal exten-
sion that ends at position 402. A combination of chemical shift
analysis, amide hydrogen exchange, and 15N relaxation showed
that phosphorylation partially undocks the 3 helix from the
PDZ3 core. The linear change in chemical shifts (Fig. 4) indi-
cates that p397-PDZ3 exists as a rapid equilibrium between a
docked state in which 3 is natively packed and an undocked
state in which “3 residues” have lost some helical character.
This conclusion was only possible because of previous charac-
terization of7ct, which eliminates the native3 by truncation
of residues 396–402 (21). In that study,3was shown to confer
a 21-fold increase in binding affinity to CRIPT peptide. With-
out 3, the PDZ3 core has enhanced side-chain dynamics that
are quenched upon CRIPT binding. This confers an entropic
penalty to binding, which was detected through isothermal
titration calorimetry. Interestingly, because 3 does not con-
tact CRIPT peptide, this was considered a novel dynamic allos-
teric mechanism. Here, we show that this dynamic mechanism
has biological significance andwas induced by phosphorylation
at Tyr-397. The 4-fold reduction in CRIPT binding affinity (as
opposed to 21-fold) is consistent with the 50% population of
undocked 3. The behavior of p397-PDZ3 also confirmed that
7ct serves as an excellent proxy for phosphorylated PDZ3
constructs.
Phosphorylation Tunes Interdomain Interactions in PDZ3-
SH3-GK MAGUK Core—A caveat of the results on p397-PDZ3
(residues 304–402) here is that the construct remains artificial
as an excised domain. (One reason in support of using this
construct is that phosphorylation at Tyr-397 was less efficient
upon further extension of the C terminus and hence yields of
such phosphorylated constructs were unacceptably low.) Nev-
ertheless, the role of the linker may be important. Although
there is no crystal structure of full-length PSD-95 or the PDZ-
SH3-GK supradomain from anyMAGUK, there is evidence for
interaction between PDZ3 and SH3-GK. From electron
microscopy, intact PSD-95 appears as a “C-shaped” arrange-
ment of domains (55). In other work, binding assays on various
constructs of PSD-95 family MAGUKs suggest interdomain
allostery between PDZ3 and the SH3-GKmodule. In the case of
PSD-95, PDZ3 (as well as PDZs 1 and 2) was shown to influence
binding of MAP1a, which binds to the GK domain (24). A sim-
ilar result was found for SAP97 (a closely related PSD-95 family
MAGUK) binding to guanylate-kinase-associated protein (56).
In the case of the PSD-95 homologue Dlg-1 from Drosophila,
PDZ3 influences binding ofGukHolder, which binds to the SH3
domain (25). Structural insight into howPDZ3 and its following
linker interact with SH3-GK is needed to unravel the basis for
these interactions and how they are regulated.
To gain insight into how PDZ3 interacts with SH3-GK and
whether phosphorylation plays a role, we studied a PDZ3-link-
er-SH3 construct. 15N T2 measurements within the PDZ3
domain for wild type as well as for a Y397E phosphomimic and
a triple phosphomimic construct, Y397E/S415E/S418E, were
made. Ser-415 and Ser-418 have also been confirmed to be
phosphorylated (28, 29), and therefore a combination of these
sites may be phosphorylated under different signaling and cell
contexts. Phosphorylation at Tyr-397 increased the mobility of
PDZ3, and this effect was increased further for the triple
mutant (Fig. 7). This is consistent with a model in which PDZ3
FIGURE 7. T2 analysis of PDZ3-SH3 wild type and Y397E and Y397E/S415E/
S418E mutants. A, T2 difference between Y397E-PDZ3-SH3 single mutant
and wild-type PDZ3-SH3. B, T2 difference between PDZ3-SH3 Y397E/S415E/
S418E triple mutant and wild-type PDZ3-SH3. C, the average T2 values for wild
type and single and triple mutants. In A and B, residues with significant T2
increases are shown as filled bars. Error bar, S.D.
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interacts with SH3-GK via the SH3 domain and phosphoryla-
tion at 397 in 3 and 415/418 in the linker disrupts this inter-
action (Fig. 8). To our knowledge, these are the first reported
physical data that relate PDZ3 to SH3 for anyMAGUK.Todate,
there are no reported structures for any construct containing
PDZ3 and SH3 domains, although structural models of PDZ3-
SH3-GK have been proposed (56, 57). The T2 results suggest
that additive phosphorylation interferes with the putative
PDZ3-SH3 interaction. Because positions 415 and 418 are well
beyond the PDZ3 domain (and extension), theT2 data also sug-
gest that the linker plays a role in the association of PDZ3 and
SH3. It is currently unknownwhether phosphorylation at these
sites occur in an ordered pattern, but it is possible that phos-
phorylation of Ser-415/Ser-418, which are seated in a putatively
flexible fragment (SSLGSG), precedes phosphorylation of Tyr-
397, which is mostly buried. Phosphorylation of Ser-415/Ser-
418 may then facilitate Tyr-397 phosphorylation by loosening
the domain packing between PDZ3 and SH3 or providing bind-
ing sites for the kinase that phosphorylates Tyr-397. Overall,
our NMR relaxation measurements suggest that phosphoryla-
tions of Tyr-397, Ser-415, and Ser-418 cooperate together to
regulate interdomain communication of PSD-95.
It is currently unclear how conserved these phosphorylation
events are. The PSD-95 family of proteins comprises PSD-95,
PSD-93, SAP97, and SAP102. Although there is high sequence
conservation in the 3 and linker among these proteins, phos-
phorylation at Tyr-397 has only been confirmed for PSD-95
and PSD-93, and phosphorylation at 415/418 has only been
observed so far in PSD-95. Although it may be possible that
differences in phosphorylation patterns in this region contrib-
ute to functional differences between these MAGUKs (which
also have functional redundancies), this cannot be resolved
until more in-depth phosphorylation mapping is carried out.
Concluding Remarks—PDZ domains are primarily appreci-
ated for their simple function of binding C-terminal sequences.
However, PDZs are typically embedded in lengthy protein
sequences characterized by multiple other structured domains
and significant stretches of unknown structure/flexibility.
Understanding native PDZ function therefore often requires
consideration of these additional elements. There are now a
number of examples of PDZ domains whose core structures are
augmented byN- orC-terminal extensions (14, 22, 58–60), and
a recent review predicts that one-third of PDZdomains contain
such structural augmentations (30). We show here that the
effects of such additional segments can be dynamically modu-
lated by phosphorylation, building upon previous work that
showed that the external segments can regulate PDZ function.
In many multidomain proteins, the role of interdomain linkers
is not well understood. By mimicking phosphorylation at Tyr-
397 and in the linker of the PDZ3-linker-SH3 construct from
PSD-95, progressive increases inmobility in PDZ3 due to linker
phosphorylation were detected. This suggests that the linker
plays a key role in supradomain assembly. We propose that
linkers inMAGUKs and in other PDZ proteins can adopt vary-
ing degrees of structure/flexibility that serve to tune interdo-
main communication.
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